A Study of MEDI-575 in Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of MEDI-575 in Japanese
patients with advanced solid tumors (dose escalation part) and hepatocellular carcinoma
(expansion part).